Explore Health Grants Nationwide

The purpose of the grant is to establish a collaborative network among healthcare systems and public health partners to enhance the safety, quality, and resilience of U.S. healthcare delivery by rapidly detecting and responding to threats to patient and healthcare worker safety. Eligible applicants include government entities, educational institutions, nonprofits, and for-profit organizations, with no single applicant required to possess all elements of the network. Specific application instructions are not provided, but applicants must adhere to funding limits to be considered responsive.

The grant aims to fund clinical trials evaluating the efficacy and safety of products for new indications or labeling changes to address unmet needs in rare neurodegenerative diseases, ultimately increasing the number of approved treatments. Eligible applicants include government entities, nonprofits, educational institutions, small businesses, and for-profit organizations. Application details are not provided, but interested parties can contact the grantor via email at terrin.brown@fda.hhs.gov for more information.

The National Cancer Institute (NCI) is offering funding to establish new cancer epidemiology cohorts aimed at addressing knowledge gaps in cancer etiology and survivorship, facilitating future studies on cancer risk and outcomes. Eligible applicants include private and public higher education institutions, government entities, nonprofit organizations, and businesses. Application details are not specified, but interested parties can contact the grantor via email at naoko.simonds@nih.gov for more information.

The grant aims to support the development of open, consensus-based data standards and terminologies for tobacco research to enhance public health outcomes related to tobacco use. Eligible applicants include government entities, small and for-profit businesses, educational institutions, and various nonprofit organizations. Application details are not provided, but interested parties can contact the grantor via email at rene.vasquez@fda.hhs.gov for more information.

The purpose of this grant is to enhance Eswatini’s response to HIV and TB by providing targeted technical support to government structures, aiming to improve the Ministry of Health's capabilities in program leadership, oversight, and service delivery. Eligible applicants include various government entities, small and for-profit businesses, educational institutions, and nonprofit organizations. Application details are not provided, but interested parties can contact the grantor at pepfarfoas@cdc.gov for more information.

The grant from the National Institute of Allergy and Infectious Diseases (NIAID) aims to support multidisciplinary research focused on advancing a cure for Hepatitis B in individuals living with HIV, emphasizing mechanisms of persistence, biomarkers, drug targets, and non-invasive diagnostics. Eligible applicants include government entities, small and for-profit businesses, educational institutions, and certain nonprofit organizations. Application details are not specified, but interested parties can contact josh.radke@nih.gov for more information.

The grant aims to support the development and promotion of innovative information sharing and research tools on the Integrated Food Safety System (IFSS) portal to enhance food safety and public health. Only current recipients of RFA-FD-20-023 are eligible to apply. For application inquiries, interested parties can contact the grantor via email at danielle.head@fda.hhs.gov.

The grant aims to enhance U.S.-Finland biomedical and behavioral research through collaborative projects that address areas like population health and disease prevention. Eligible applicants include U.S. institutions that partner with Finnish investigators approved by the Research Council of Finland, as well as various nonprofit, government, educational, and business entities. Applications must be submitted through the NIH, which will oversee the funding process for U.S. components, while RCF will fund the Finnish participants.

The NHLBI is seeking applications for a Clinical Trial Center (CTC) and up to seven Clinical Centers (CCs) as part of the HeartShare 2.0 program, which focuses on precision clinical trials for heart failure with preserved ejection fraction (HFpEF). Eligible applicants include various government entities, nonprofit organizations, educational institutions, and for-profit businesses. Applications are not currently being solicited, but interested parties are encouraged to prepare collaborations and projects in anticipation of the funding opportunity.

The grant aims to enhance laboratory diagnostic services for HIV, TB, and related diseases in Caribbean countries by supporting laboratory accreditation, workforce training, and improving diagnostic capacity. Eligible applicants include government entities, for-profit and nonprofit organizations, and educational institutions. To apply, interested parties should contact the CDC via email at pepfarfoas@cdc.gov for further information.

The purpose of this SAMHSA grant program is to enhance training for primary care providers in the prevention and treatment of opioid use disorders (OUD) and chronic pain, with a focus on increasing access to medication-assisted treatment (MAT). Eligible applicants include national professional medical organizations authorized by the Drug Addiction Treatment Act of 2000, such as ASAM, AAAP, AMA, AOAAM, and APA. Application details are not provided, but interested parties can contact Humberto Carvalho at the provided email for further information.

The purpose of this grant is to provide technical assistance and support for the implementation of HIV and TB prevention and treatment services in Mozambique, focusing on capacity building for Provincial Health Directorates and other stakeholders. Eligible applicants include government entities, educational institutions, nonprofits, and businesses, including small and for-profit organizations. To apply, interested parties should contact the grantor via email at pepfarfoas@cdc.gov for further information.